Crumbling over the COVID-19 vaccination since last few days, the national capital is now comparitively relieved as it has received adequate amount of vaccines to carry on the vaccination drive. Delhi has now received 1,27,420 doses of Covishield, manufactured by the Serum Institute. This is for use among adults in the 18-44 years age group.
Due to scarcity of vaccines, the government had to forceibly suspend the inoculation drive for the 18-44 years age group towards the end of May till some supplies were restored last week.
Besides, it has also received 20,000 more doses of Covaxin for the same age group.
On June 6, the Delhi government had received 40,000 doses of Covaxin, helping the administration revive the vaccination drive, although only for those who were due for second dose of vaccine. However, with additional stock of Covishield, even those needing the first dose can be catered to free of cost.
Last month, Delhi Deputy Chief Minister Manish Sisodia had accused the Centre of stubbornly "sitting over" the vaccine distribution system, and asked how private hospitals were receiving doses if there were not enough stocks with it.
Notably, the Delhi government had also floated global tender towards the end of May for the procurement of 10 million doses of vaccines on an urgent basis.
Meanwhile, Delhi recorded 337 fresh infections and 36 fatalities in a single day, with a positivity rate of 0.46 per cent on Wednesday. The number of new coronavirus cases and the positivity rate saw a slight increase from Tuesday's figures. The national capital recorded 316 cases with a positivity rate of 0.44 per cent, and 41 fatalities, according to the health bulletin released on Tuesday.
